Cite

    Zhang, Z., Zhang, F., Yuan, F., Li, Y., Ma, J., Ou, Q., Liu, Z., Yang, B., Wang, L., Tao, H., Zhang, S., Li, X., Zhi, X., Ge, X., Bao, H., Wu, X., Hu, Y., & Wang, J. (2020). pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Therapeutic advances in medical oncology, 12, . http://access.bl.uk/ark:/81055/vdc_100109398886.0x00023a